Sauzanne Khalilieh

1.1k total citations
32 papers, 802 citations indexed

About

Sauzanne Khalilieh is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Sauzanne Khalilieh has authored 32 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Immunology. Recurrent topics in Sauzanne Khalilieh's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Sauzanne Khalilieh is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Sauzanne Khalilieh collaborates with scholars based in United States, Denmark and Belgium. Sauzanne Khalilieh's co-authors include Ka Lai Yee, Marian Iwamoto, Rosa I. Sánchez, Fan Li, Diana Montgomery, Paul Stryszak, H Magnussen, Olaf Holz, Paresh Soni and Jonathan Sadeh and has published in prestigious journals such as Nature, Gastroenterology and Biological Psychiatry.

In The Last Decade

Sauzanne Khalilieh

32 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sauzanne Khalilieh United States 17 311 284 147 138 134 32 802
A. Castley Australia 5 238 0.8× 263 0.9× 217 1.5× 76 0.6× 70 0.5× 8 1.1k
О. А. Козырев Russia 2 197 0.6× 249 0.9× 155 1.1× 75 0.5× 78 0.6× 7 1.2k
E. Jägel-Guedes Germany 3 199 0.6× 251 0.9× 156 1.1× 75 0.5× 78 0.6× 6 1.2k
D. Thorborn United Kingdom 7 241 0.8× 271 1.0× 169 1.1× 80 0.6× 83 0.6× 15 1.4k
Alastair Benbow United Kingdom 4 205 0.7× 249 0.9× 156 1.1× 75 0.5× 78 0.6× 6 1.2k
Christiansen Ft Australia 4 242 0.8× 226 0.8× 165 1.1× 80 0.6× 69 0.5× 6 1.1k
Thawinee Jantararoungtong Thailand 17 151 0.5× 143 0.5× 56 0.4× 99 0.7× 88 0.7× 28 1.1k
Rebecca Pavlos Australia 15 168 0.5× 79 0.3× 31 0.2× 184 1.3× 89 0.7× 24 882
Soraya Fellahi France 17 59 0.2× 162 0.6× 146 1.0× 19 0.1× 73 0.5× 34 774
Benno Schnyder Switzerland 23 477 1.5× 52 0.2× 19 0.1× 524 3.8× 445 3.3× 39 2.0k

Countries citing papers authored by Sauzanne Khalilieh

Since Specialization
Citations

This map shows the geographic impact of Sauzanne Khalilieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sauzanne Khalilieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sauzanne Khalilieh more than expected).

Fields of papers citing papers by Sauzanne Khalilieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sauzanne Khalilieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sauzanne Khalilieh. The network helps show where Sauzanne Khalilieh may publish in the future.

Co-authorship network of co-authors of Sauzanne Khalilieh

This figure shows the co-authorship network connecting the top 25 collaborators of Sauzanne Khalilieh. A scholar is included among the top collaborators of Sauzanne Khalilieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sauzanne Khalilieh. Sauzanne Khalilieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Sean M., Jason M. Uslaner, Monika Kandebo, et al.. (2022). P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor. Biological Psychiatry. 91(9). S309–S310. 1 indexed citations
2.
Zhong, Wenjun, Xinyue Liu, Tiffini Voss, et al.. (2021). Medications in Patients with Dementia and Behavioral Disturbance. Journal of Alzheimer s Disease Reports. 5(1). 535–540. 6 indexed citations
3.
Khalilieh, Sauzanne, Ka Lai Yee, Rosa I. Sánchez, et al.. (2020). Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions. Clinical Drug Investigation. 40(10). 927–946. 17 indexed citations
4.
Yee, Ka Lai, Tamara D. Cabalu, Yuhsin Kuo, et al.. (2020). Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin. The Journal of Clinical Pharmacology. 61(3). 394–405. 5 indexed citations
5.
Khalilieh, Sauzanne, Ka Lai Yee, Rosa I. Sánchez, et al.. (2019). Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone. Clinical Pharmacology in Drug Development. 9(2). 151–161. 6 indexed citations
6.
Sánchez, Rosa I., Ka Lai Yee, Fan Li, et al.. (2019). Investigation of Pharmacokinetic Interactions between Doravirine and Elbasvir-Grazoprevir and Ledipasvir-Sofosbuvir. Antimicrobial Agents and Chemotherapy. 63(5). 14 indexed citations
7.
Khalilieh, Sauzanne, et al.. (2018). Pharmacokinetics of Tildrakizumab (MK‐3222), an Anti‐IL‐23 Monoclonal Antibody, After Intravenous or Subcutaneous Administration in Healthy Subjects. Basic & Clinical Pharmacology & Toxicology. 123(3). 294–300. 30 indexed citations
8.
Khalilieh, Sauzanne, Azher Hussain, Diana Montgomery, et al.. (2018). Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis. British Journal of Clinical Pharmacology. 84(10). 2292–2302. 28 indexed citations
9.
Yee, Ka Lai, Sauzanne Khalilieh, Rosa I. Sánchez, et al.. (2017). The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects. Clinical Drug Investigation. 37(7). 659–667. 40 indexed citations
10.
Khalilieh, Sauzanne, Ka Lai Yee, Fan Li, et al.. (2017). A Randomized Trial to Assess the Effect of Doravirine on the QTc Interval Using a Single Supratherapeutic Dose in Healthy Adult Volunteers. Clinical Drug Investigation. 37(10). 975–984. 9 indexed citations
11.
Yee, Ka Lai, Rosa I. Sánchez, Rachael Liu, et al.. (2016). Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 61(2). 23 indexed citations
12.
Anderson, Matt S., Sauzanne Khalilieh, Ka Lai Yee, et al.. (2016). A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir. Clinical Pharmacokinetics. 56(6). 661–669. 25 indexed citations
13.
Khalilieh, Sauzanne, Hwa-ping Feng, Ellen G. J. Hulskotte, Larissa Wenning, & Joan R. Butterton. (2015). Clinical Pharmacology Profile of Boceprevir, a Hepatitis C Virus NS3 Protease Inhibitor: Focus on Drug–Drug Interactions. Clinical Pharmacokinetics. 54(6). 599–614. 6 indexed citations
14.
Hastrup, Nina, Sauzanne Khalilieh, David C. Dale, et al.. (2015). The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects. Cytokine. 72(2). 197–203. 12 indexed citations
15.
Kopp, Tamara, Elisabeth Riedl, Christine Bangert, et al.. (2015). Clinical improvement in psoriasis with specific targeting of interleukin-23. Nature. 521(7551). 222–226. 165 indexed citations
16.
Seiberling, Michael, et al.. (2013). Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30days with MK-7123, a selective CXCR2 antagonist. International Immunopharmacology. 17(2). 178–183. 10 indexed citations
17.
18.
Holz, Olaf, Sauzanne Khalilieh, Andrea Ludwig-Sengpiel, et al.. (2009). SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects. European Respiratory Journal. 35(3). 564–570. 150 indexed citations
19.
Gupta, Samir K., Sauzanne Khalilieh, Bhavna Kantesaria, & Christopher Banfield. (2006). Pharmacokinetics of desloratadine in children between 2 and 11 years of age. British Journal of Clinical Pharmacology. 63(5). 534–540. 19 indexed citations
20.
Zhou, Honghui, et al.. (2000). Effect of gastric ph on plasma concentrations of tegaserod (HTF 919) and its major metabolite in healthy subjects. Gastroenterology. 118(4). A1206–A1207. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Castley Breakdown of academic impact, for papers by О. А. Козырев Breakdown of academic impact, for papers by E. Jägel-Guedes Breakdown of academic impact, for papers by D. Thorborn Breakdown of academic impact, for papers by Alastair Benbow Breakdown of academic impact, for papers by Christiansen Ft Breakdown of academic impact, for papers by Thawinee Jantararoungtong Breakdown of academic impact, for papers by Rebecca Pavlos Breakdown of academic impact, for papers by Soraya Fellahi Breakdown of academic impact, for papers by Benno Schnyder
Rankless by CCL
2026